2009
DOI: 10.1002/ppul.20983
|View full text |Cite
|
Sign up to set email alerts
|

Unorthodox long‐term aerosolized ampicillin use for methicillin‐susceptible Staphylococcus aureus lung infection in a cystic fibrosis patient

Abstract: Staphylococcus aureus is a significant cause of pulmonary colonization in cystic fibrosis (CF) patients. The optimal strategy of therapy in chronically infected patients with this pathogen is not yet established. We report a successful long-term aerosolized ampicillin treatment of a 14-year-old girl with chronic symptomatic S. aureus lung infection.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
1
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 11 publications
(2 citation statements)
references
References 21 publications
1
1
0
Order By: Relevance
“…In February 2007, due to frequent PE and rapid LF decline, she was started on aerosolized ampicillin (Gobemicina®, Normon Laboratories, Madrid, Spain) every 12 hours. As previously reported [21], the response to this treatment was excellent for a year. On February 2008 she again suffered severe and frequent PE, even while on aerosolized ampicillin, and always related to menstrual cycle as described above.…”
Section: Case Presentationsupporting
confidence: 79%
“…In February 2007, due to frequent PE and rapid LF decline, she was started on aerosolized ampicillin (Gobemicina®, Normon Laboratories, Madrid, Spain) every 12 hours. As previously reported [21], the response to this treatment was excellent for a year. On February 2008 she again suffered severe and frequent PE, even while on aerosolized ampicillin, and always related to menstrual cycle as described above.…”
Section: Case Presentationsupporting
confidence: 79%
“…One case report reported a successful long-term aerosolised ampicillin treatment of a 14-year-old girl with chronic symptomatic S aureus lung infection (Máiz 2009).…”
Section: Agreements and Disagreements With Other Studies Or Reviewsmentioning
confidence: 99%